These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20864135)

  • 1. Re: prostate specific antigen decrease and prostate cancer diagnosis: antibiotic versus placebo prospective randomized clinical trial: R. M. Stopiglia, U. Ferreira, M. M. Silva, W. E. Matheus, f. Denardi and L. O. Reis J Urol 2010; 183: 940-945.
    Yoon DK; Park HS; Park JY
    J Urol; 2010 Nov; 184(5):2214-5; author reply 2215. PubMed ID: 20864135
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. S. J. Freedland, E. A. Platz, J. C. Presti Jr., W. J. Aronson, C. L. Amling, C. J. Kane and M. K. Terris. J Urol, 175: 500-504, 2006.
    Stamatiou K; Alevizos A; Mariolis A; Sofras F
    J Urol; 2006 Sep; 176(3):1251-2; author reply 1252. PubMed ID: 16890735
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostate specific antigen decrease and prostate cancer diagnosis: antibiotic versus placebo prospective randomized clinical trial.
    Stopiglia RM; Ferreira U; Silva MM; Matheus WE; Denardi F; Reis LO
    J Urol; 2010 Mar; 183(3):940-4. PubMed ID: 20089269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Prediagnosis prostate specific antigen velocity is associated with risk of prostate cancer progression following brachytherapy and external beam radiation therapy. S. E. Eggener, K. A. Roehl, O. Yossepowitch and W. J. Catalona, J Urol 2006; 176: 1399-1403.
    Wagner MD; Daneshmand S; Sokoloff M; Barry JM
    J Urol; 2007 Jun; 177(6):2396; author reply 2396-7. PubMed ID: 17509368
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: It's time to abandon an upper limit of normal for prostate specific antigen: assessing the risk of prostate cancer: I. M. Thompson, D. P. Ankerst, R. Etzioni and T. Wang J Urol 2008; 180: 1219-1222.
    Walsh PC
    J Urol; 2009 Mar; 181(3):1499; author reply 1499-500. PubMed ID: 19157429
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter to the Editor; Re: Wirth MP, Weissbach L, Marx F-J, Heckl W, Jellinghaus W, Riedmiller H, Noack B, Hinke A, Froehner M. Prospective randomized trial comparing flutamide as adjuvant treatment versus observation after radical prostatectomy for locally advanced, lymph node-negative prostate cancer. Eur Urol 2004;45:267-70.
    Rocco B; Matei DV; de Cobelli O; Rocco F
    Eur Urol; 2004 Aug; 46(2):272-3; author reply 273. PubMed ID: 15245825
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Monique J. Roobol, Ewout W. Steyerberg, Ries Kranse, et al. A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer. Eur Urol 2010;57:79-85.
    Morrod D
    Eur Urol; 2010 Sep; 58(3):327; author reply 328-30. PubMed ID: 20598799
    [No Abstract]   [Full Text] [Related]  

  • 8. Impacts of antibiotic and anti-inflammatory therapies on serum prostate-specific antigen levels in the presence of prostatic inflammation: a prospective randomized controlled trial.
    Ugurlu O; Yaris M; Oztekin CV; Kosan TM; Adsan O; Cetinkaya M
    Urol Int; 2010; 84(2):185-90. PubMed ID: 20215823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Effectiveness of antibiotics given to asymptomatic men for an increased prostate specific antigen. S. Baltaci, E. Suer, A. H. Haliloglu, M. I. Gokce, A. H. Elhan and Y. Beduk. J Urol 2009; 181: 128-132.
    Eggener SE; Raman JD
    J Urol; 2009 Jul; 182(1):396-7. PubMed ID: 19467675
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia.
    Andriole GL; Roehrborn C; Schulman C; Slawin KM; Somerville M; Rittmaster RS
    Urology; 2004 Sep; 64(3):537-41; discussion 542-3. PubMed ID: 15351586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial comment on: Is prostate-specific antigen velocity selective for clinically significant prostate cancer in screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam).
    Terris MK
    Eur Urol; 2009 Feb; 55(2):392; discussion 393. PubMed ID: 18353530
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial comment. Correlation between serum prostate-specific antigen and cancer volume in prostate glands of different sizes.
    Autorino R; Perdonà S; Di Lorenzo G
    Urology; 2010 Nov; 76(5):1076; author reply 1076-7. PubMed ID: 21056255
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening for prostate cancer with serum prostate-specific antigen : what should we recommend while waiting for randomized clinical trial results?
    Davis JW
    Cancer; 2008 Dec; 113(11):3067-8. PubMed ID: 18932255
    [No Abstract]   [Full Text] [Related]  

  • 14. [Early detection of prostatic carcinoma: Is PSA screening suitable?].
    Kaulen H
    Dtsch Med Wochenschr; 2003 May; 128(18):977. PubMed ID: 12755136
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?
    Ansari MS
    J Urol; 2002 Jul; 168(1):200; author reply 200-1. PubMed ID: 12050532
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomized trial results did not resolve controversies surrounding prostate cancer screening.
    Hoffman RM
    Curr Opin Urol; 2010 May; 20(3):189-93. PubMed ID: 20224414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: The performance of prostate specific antigen for predicting prostate cancer is maintained after a prior negative prostate biopsy I. M. Thompson, C. M. Tangen, D. P. Ankerst, C. Chi, M. S. Lucia, P. Goodman, H. Parnes and C. A. Coltman, Jr. J Urol 2008; 180: 544-547.
    Atmaca AF; Balbay MD
    J Urol; 2009 May; 181(5):2387-8. PubMed ID: 19303084
    [No Abstract]   [Full Text] [Related]  

  • 18. Prospective validation of active surveillance in prostate cancer: the PRIAS study.
    van den Bergh RC; Roemeling S; Roobol MJ; Roobol W; Schröder FH; Bangma CH
    Eur Urol; 2007 Dec; 52(6):1560-3. PubMed ID: 17532115
    [No Abstract]   [Full Text] [Related]  

  • 19. Early versus delayed intervention for prostate cancer: the case for early intervention.
    Loeb S; Catalona WJ
    Nat Clin Pract Urol; 2007 Jul; 4(7):348-9. PubMed ID: 17563779
    [No Abstract]   [Full Text] [Related]  

  • 20. [The usefulness of percentage of free prostate specific antigen/prostate specific antigen density in the diagnosis of prostate cancer].
    Han G; Gao JP; Cao XL; Hong BF; Tang J
    Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(6):379-81. PubMed ID: 16638346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.